Beauhurst：2026年英国衍生企业投资报告（英文版）（10页）.pdf

1、into SpinoutsInvestmentInsights on investment data from 202520263Investment into Spinouts 2026ContentsHaving spent many years advising life sciences and technology spinouts from Oxford,Cambridge,Imperial and other leading research institutions,I have watched the UK spinout ecosystem mature into one

2、of the worlds most dynamic.2025 has tested that resilience,but the fundamentals remain strong.Equity investment of 1.96b and 384 deals seems to represent a more selective market,not a broken one.Capital is still being deployed to high potential businesses,and the shift towards earlier-stage rounds s

3、hows investors still backing promising technology at the outset.Digital and AI-focused spinouts have performed especially well,with Artificial Intelligence recording 71 deals and several sub-sectors within Digital and Technologies exceeding their three-year averages on deal value.In our practice,we

4、continue to see founders working on genuinely world-changing problems in medicine,cleantech,AI and beyond,attracting serious investor interest.The Golden Triangle universities continue to lead,with Cambridge and Oxford spinouts combined raising more than 800m in 2025,but regional ecosystems are show

5、ing growing strength,including in Edinburgh,Bristol and Manchester.Public investors like Scottish Enterprise have played a vital anchoring role outside the South East.Grant funding has contracted,and the pause in Innovate UKs Smart Grants programme created disruption.But the governments Modern Indus

6、trial Strategy and Life Sciences Sector Plan signal a clear long-term commitment to the sectors that spinouts disproportionately represent.The last year has seen a number of high value exits,including$1b+exits for OrganOx and Oxford Ionics,demonstrating the returns which this sector can generate and